According to this latest study, the 2021 growth of Peripheral Drug-Coated Balloon will have significant change from previous year. By the most conservative estimates of global Peripheral Drug-Coated Balloon market size (most likely outcome) will be a year-over-year revenue growth rate of % in 2021, from US$ million in 2020. Over the next five years the Peripheral Drug-Coated Balloon market will register a % CAGR in terms of revenue, the global market size will reach US$ million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Peripheral Drug-Coated Balloon market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Paclitaxel
Sirolimus
Others
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Hospital
Clinic
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Cordis
Defibtech
Abbott Laboratories
REVA Medical
Shimadzu
Opto Circuits
Biotronik
Endologix
SMT
Philips Healthcare
Elixir Medical
CorMatrix Cardiovascular
Advanced Cardiac Therapeutics
Edwards Lifesciences
Impulse Dynamics
Stereotaxis
Table of Contents1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Peripheral Drug-Coated Balloon Consumption 2016-2026
2.1.2 Peripheral Drug-Coated Balloon Consumption CAGR by Region
2.2 Peripheral Drug-Coated Balloon Segment by Type
2.2.1 Paclitaxel
2.2.2 Sirolimus
2.2.3 Others
2.3 Peripheral Drug-Coated Balloon Sales by Type
2.3.1 Global Peripheral Drug-Coated Balloon Sales Market Share by Type (2016-2021)
2.3.2 Global Peripheral Drug-Coated Balloon Revenue and Market Share by Type (2016-2021)
2.3.3 Global Peripheral Drug-Coated Balloon Sale Price by Type (2016-2021)
2.4 Peripheral Drug-Coated Balloon Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Peripheral Drug-Coated Balloon Sales by Application
2.5.1 Global Peripheral Drug-Coated Balloon Sale Market Share by Application (2016-2021)
2.5.2 Global Peripheral Drug-Coated Balloon Revenue and Market Share by Application (2016-2021)
2.5.3 Global Peripheral Drug-Coated Balloon Sale Price by Application (2016-2021)
3 Global Peripheral Drug-Coated Balloon by Company
3.1 Global Peripheral Drug-Coated Balloon Sales Market Share by Company
3.1.1 Global Peripheral Drug-Coated Balloon Sales by Company (2019-2021)
3.1.2 Global Peripheral Drug-Coated Balloon Sales Market Share by Company (2019-2021)
3.2 Global Peripheral Drug-Coated Balloon Revenue Market Share by Company
3.2.1 Global Peripheral Drug-Coated Balloon Revenue by Company (2019-2021)
3.2.2 Global Peripheral Drug-Coated Balloon Revenue Market Share by Company (2019-2021)
3.3 Global Peripheral Drug-Coated Balloon Sale Price by Company
3.4 Global Manufacturers Peripheral Drug-Coated Balloon Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Peripheral Drug-Coated Balloon Product Location Distribution
3.4.2 Players Peripheral Drug-Coated Balloon Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Peripheral Drug-Coated Balloon by Region
4.1 Global Peripheral Drug-Coated Balloon by Region
4.1.1 Global Peripheral Drug-Coated Balloon Sales by Region
4.1.2 Global Peripheral Drug-Coated Balloon Revenue by Region
4.2 Americas Peripheral Drug-Coated Balloon Sales Growth
4.3 APAC Peripheral Drug-Coated Balloon Sales Growth
4.4 Europe Peripheral Drug-Coated Balloon Sales Growth
4.5 Middle East & Africa Peripheral Drug-Coated Balloon Sales Growth
5 Americas
5.1 Americas Peripheral Drug-Coated Balloon Sales by Country
5.1.1 Americas Peripheral Drug-Coated Balloon Sales by Country (2016-2021)
5.1.2 Americas Peripheral Drug-Coated Balloon Revenue by Country (2016-2021)
5.2 Americas Peripheral Drug-Coated Balloon Sales by Type
5.3 Americas Peripheral Drug-Coated Balloon Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Peripheral Drug-Coated Balloon Sales by Region
6.1.1 APAC Peripheral Drug-Coated Balloon Sales by Region (2016-2021)
6.1.2 APAC Peripheral Drug-Coated Balloon Revenue by Region (2016-2021)
6.2 APAC Peripheral Drug-Coated Balloon Sales by Type
6.3 APAC Peripheral Drug-Coated Balloon Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Peripheral Drug-Coated Balloon by Country
7.1.1 Europe Peripheral Drug-Coated Balloon Sales by Country (2016-2021)
7.1.2 Europe Peripheral Drug-Coated Balloon Revenue by Country (2016-2021)
7.2 Europe Peripheral Drug-Coated Balloon Sales by Type
7.3 Europe Peripheral Drug-Coated Balloon Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Peripheral Drug-Coated Balloon by Country
8.1.1 Middle East & Africa Peripheral Drug-Coated Balloon Sales by Country (2016-2021)
8.1.2 Middle East & Africa Peripheral Drug-Coated Balloon Revenue by Country (2016-2021)
8.2 Middle East & Africa Peripheral Drug-Coated Balloon Sales by Type
8.3 Middle East & Africa Peripheral Drug-Coated Balloon Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Peripheral Drug-Coated Balloon Distributors
10.3 Peripheral Drug-Coated Balloon Customer
11 Global Peripheral Drug-Coated Balloon Market Forecast
11.1 Global Peripheral Drug-Coated Balloon Forecast by Region
11.1.1 Global Peripheral Drug-Coated Balloon Forecast by Regions (2021-2026)
11.2.2 Global Peripheral Drug-Coated Balloon Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Peripheral Drug-Coated Balloon Forecast by Type
11.7 Global Peripheral Drug-Coated Balloon Forecast by Application
12 Key Players Analysis
12.1 Cordis
12.1.1 Cordis Company Information
12.1.2 Cordis Peripheral Drug-Coated Balloon Product Offered
12.1.3 Cordis Peripheral Drug-Coated Balloon Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Cordis Main Business Overview
12.1.5 Cordis Latest Developments
12.2 Defibtech
12.2.1 Defibtech Company Information
12.2.2 Defibtech Peripheral Drug-Coated Balloon Product Offered
12.2.3 Defibtech Peripheral Drug-Coated Balloon Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Defibtech Main Business Overview
12.2.5 Defibtech Latest Developments
12.3 Abbott Laboratories
12.3.1 Abbott Laboratories Company Information
12.3.2 Abbott Laboratories Peripheral Drug-Coated Balloon Product Offered
12.3.3 Abbott Laboratories Peripheral Drug-Coated Balloon Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Abbott Laboratories Main Business Overview
12.3.5 Abbott Laboratories Latest Developments
12.4 REVA Medical
12.4.1 REVA Medical Company Information
12.4.2 REVA Medical Peripheral Drug-Coated Balloon Product Offered
12.4.3 REVA Medical Peripheral Drug-Coated Balloon Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 REVA Medical Main Business Overview
12.4.5 REVA Medical Latest Developments
12.5 Shimadzu
12.5.1 Shimadzu Company Information
12.5.2 Shimadzu Peripheral Drug-Coated Balloon Product Offered
12.5.3 Shimadzu Peripheral Drug-Coated Balloon Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Shimadzu Main Business Overview
12.5.5 Shimadzu Latest Developments
12.6 Opto Circuits
12.6.1 Opto Circuits Company Information
12.6.2 Opto Circuits Peripheral Drug-Coated Balloon Product Offered
12.6.3 Opto Circuits Peripheral Drug-Coated Balloon Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Opto Circuits Main Business Overview
12.6.5 Opto Circuits Latest Developments
12.7 Biotronik
12.7.1 Biotronik Company Information
12.7.2 Biotronik Peripheral Drug-Coated Balloon Product Offered
12.7.3 Biotronik Peripheral Drug-Coated Balloon Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Biotronik Main Business Overview
12.7.5 Biotronik Latest Developments
12.8 Endologix
12.8.1 Endologix Company Information
12.8.2 Endologix Peripheral Drug-Coated Balloon Product Offered
12.8.3 Endologix Peripheral Drug-Coated Balloon Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Endologix Main Business Overview
12.8.5 Endologix Latest Developments
12.9 SMT
12.9.1 SMT Company Information
12.9.2 SMT Peripheral Drug-Coated Balloon Product Offered
12.9.3 SMT Peripheral Drug-Coated Balloon Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 SMT Main Business Overview
12.9.5 SMT Latest Developments
12.10 Philips Healthcare
12.10.1 Philips Healthcare Company Information
12.10.2 Philips Healthcare Peripheral Drug-Coated Balloon Product Offered
12.10.3 Philips Healthcare Peripheral Drug-Coated Balloon Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Philips Healthcare Main Business Overview
12.10.5 Philips Healthcare Latest Developments
12.11 Elixir Medical
12.11.1 Elixir Medical Company Information
12.11.2 Elixir Medical Peripheral Drug-Coated Balloon Product Offered
12.11.3 Elixir Medical Peripheral Drug-Coated Balloon Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Elixir Medical Main Business Overview
12.11.5 Elixir Medical Latest Developments
12.12 CorMatrix Cardiovascular
12.12.1 CorMatrix Cardiovascular Company Information
12.12.2 CorMatrix Cardiovascular Peripheral Drug-Coated Balloon Product Offered
12.12.3 CorMatrix Cardiovascular Peripheral Drug-Coated Balloon Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 CorMatrix Cardiovascular Main Business Overview
12.12.5 CorMatrix Cardiovascular Latest Developments
12.13 Advanced Cardiac Therapeutics
12.13.1 Advanced Cardiac Therapeutics Company Information
12.13.2 Advanced Cardiac Therapeutics Peripheral Drug-Coated Balloon Product Offered
12.13.3 Advanced Cardiac Therapeutics Peripheral Drug-Coated Balloon Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Advanced Cardiac Therapeutics Main Business Overview
12.13.5 Advanced Cardiac Therapeutics Latest Developments
12.14 Edwards Lifesciences
12.14.1 Edwards Lifesciences Company Information
12.14.2 Edwards Lifesciences Peripheral Drug-Coated Balloon Product Offered
12.14.3 Edwards Lifesciences Peripheral Drug-Coated Balloon Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 Edwards Lifesciences Main Business Overview
12.14.5 Edwards Lifesciences Latest Developments
12.15 Impulse Dynamics
12.15.1 Impulse Dynamics Company Information
12.15.2 Impulse Dynamics Peripheral Drug-Coated Balloon Product Offered
12.15.3 Impulse Dynamics Peripheral Drug-Coated Balloon Sales, Revenue, Price and Gross Margin (2019-2021)
12.15.4 Impulse Dynamics Main Business Overview
12.15.5 Impulse Dynamics Latest Developments
12.16 Stereotaxis
12.16.1 Stereotaxis Company Information
12.16.2 Stereotaxis Peripheral Drug-Coated Balloon Product Offered
12.16.3 Stereotaxis Peripheral Drug-Coated Balloon Sales, Revenue, Price and Gross Margin (2019-2021)
12.16.4 Stereotaxis Main Business Overview
12.16.5 Stereotaxis Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Peripheral Drug-Coated Balloon Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Paclitaxel
Table 3. Major Players of Sirolimus
Table 4. Major Players of Others
Table 5. Global Peripheral Drug-Coated Balloon Sales by Type (2016-2021) & (K Units)
Table 6. Global Peripheral Drug-Coated Balloon Sales Market Share by Type (2016-2021)
Table 7. Global Peripheral Drug-Coated Balloon Revenue by Type (2016-2021) & ($ million)
Table 8. Global Peripheral Drug-Coated Balloon Revenue Market Share by Type (2016-2021)
Table 9. Global Peripheral Drug-Coated Balloon Sale Price by Type (2016-2021)
Table 10. Global Peripheral Drug-Coated Balloon Sales by Application (2016-2021) & (K Units)
Table 11. Global Peripheral Drug-Coated Balloon Sales Market Share by Application (2016-2021)
Table 12. Global Peripheral Drug-Coated Balloon Value by Application (2016-2021)
Table 13. Global Peripheral Drug-Coated Balloon Revenue Market Share by Application (2016-2021)
Table 14. Global Peripheral Drug-Coated Balloon Sale Price by Application (2016-2021)
Table 15. Global Peripheral Drug-Coated Balloon Sales by Company (2019-2021) & (K Units)
Table 16. Global Peripheral Drug-Coated Balloon Sales Market Share by Company (2019-2021)
Table 17. Global Peripheral Drug-Coated Balloon Revenue by Company (2019-2021) ($ Millions)
Table 18. Global Peripheral Drug-Coated Balloon Revenue Market Share by Company (2019-2021)
Table 19. Global Peripheral Drug-Coated Balloon Sale Price by Company (2019-2021)
Table 20. Key Manufacturers Peripheral Drug-Coated Balloon Producing Area Distribution and Sales Area
Table 21. Players Peripheral Drug-Coated Balloon Products Offered
Table 22. Peripheral Drug-Coated Balloon Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Peripheral Drug-Coated Balloon Sales by Region (2016-2021) (K Units)
Table 26. Global Peripheral Drug-Coated Balloon Sales Market Share by Region (2016-2021)
Table 27. Global Peripheral Drug-Coated Balloon Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global Peripheral Drug-Coated Balloon Revenue Market Share by Region (2016-2021)
Table 29. Americas Peripheral Drug-Coated Balloon Sales by Country (2016-2021) & (K Units)
Table 30. Americas Peripheral Drug-Coated Balloon Sales Market Share by Country (2016-2021)
Table 31. Americas Peripheral Drug-Coated Balloon Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas Peripheral Drug-Coated Balloon Revenue Market Share by Country (2016-2021)
Table 33. Americas Peripheral Drug-Coated Balloon Sales by Type (2016-2021) & (K Units)
Table 34. Americas Peripheral Drug-Coated Balloon Sales Market Share by Type (2016-2021)
Table 35. Americas Peripheral Drug-Coated Balloon Sales by Application (2016-2021) & (K Units)
Table 36. Americas Peripheral Drug-Coated Balloon Sales Market Share by Application (2016-2021)
Table 37. APAC Peripheral Drug-Coated Balloon Sales by Region (2016-2021) & (K Units)
Table 38. APAC Peripheral Drug-Coated Balloon Sales Market Share by Region (2016-2021)
Table 39. APAC Peripheral Drug-Coated Balloon Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC Peripheral Drug-Coated Balloon Revenue Market Share by Region (2016-2021)
Table 41. APAC Peripheral Drug-Coated Balloon Sales by Type (2016-2021) & (K Units)
Table 42. APAC Peripheral Drug-Coated Balloon Sales Market Share by Type (2016-2021)
Table 43. APAC Peripheral Drug-Coated Balloon Sales by Application (2016-2021) & (K Units)
Table 44. APAC Peripheral Drug-Coated Balloon Sales Market Share by Application (2016-2021)
Table 45. Europe Peripheral Drug-Coated Balloon Sales by Country (2016-2021) & (K Units)
Table 46. Europe Peripheral Drug-Coated Balloon Sales Market Share by Country (2016-2021)
Table 47. Europe Peripheral Drug-Coated Balloon Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe Peripheral Drug-Coated Balloon Revenue Market Share by Country (2016-2021)
Table 49. Europe Peripheral Drug-Coated Balloon Sales by Type (2016-2021) & (K Units)
Table 50. Europe Peripheral Drug-Coated Balloon Sales Market Share by Type (2016-2021)
Table 51. Europe Peripheral Drug-Coated Balloon Sales by Application (2016-2021) & (K Units)
Table 52. Europe Peripheral Drug-Coated Balloon Sales Market Share by Application (2016-2021)
Table 53. Middle East & Africa Peripheral Drug-Coated Balloon Sales by Country (2016-2021) & (K Units)
Table 54. Middle East & Africa Peripheral Drug-Coated Balloon Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa Peripheral Drug-Coated Balloon Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa Peripheral Drug-Coated Balloon Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa Peripheral Drug-Coated Balloon Sales by Type (2016-2021) & (K Units)
Table 58. Middle East & Africa Peripheral Drug-Coated Balloon Sales Market Share by Type (2016-2021)
Table 59. Middle East & Africa Peripheral Drug-Coated Balloon Sales by Application (2016-2021) & (K Units)
Table 60. Middle East & Africa Peripheral Drug-Coated Balloon Sales Market Share by Application (2016-2021)
Table 61. Key and Potential Regions of Peripheral Drug-Coated Balloon
Table 62. Key Application and Potential Industries of Peripheral Drug-Coated Balloon
Table 63. Key Challenges of Peripheral Drug-Coated Balloon
Table 64. Key Trends of Peripheral Drug-Coated Balloon
Table 65. Peripheral Drug-Coated Balloon Distributors List
Table 66. Peripheral Drug-Coated Balloon Customer List
Table 67. Global Peripheral Drug-Coated Balloon Sales Forecast by Region (2021-2026) & (K Units)
Table 68. Global Peripheral Drug-Coated Balloon Consumption Market Forecast by Region
Table 69. Global Peripheral Drug-Coated Balloon Revenue Forecast by Region (2021-2026) & ($ millions)
Table 70. Global Peripheral Drug-Coated Balloon Revenue Market Share Forecast by Region (2021-2026)
Table 71. Americas Peripheral Drug-Coated Balloon Sales Forecast by Country (2021-2026) & (K Units)
Table 72. Americas Peripheral Drug-Coated Balloon Revenue Forecast by Country (2021-2026) & ($ millions)
Table 73. APAC Peripheral Drug-Coated Balloon Sales Forecast by Region (2021-2026) & (K Units)
Table 74. APAC Peripheral Drug-Coated Balloon Revenue Forecast by Region (2021-2026) & ($ millions)
Table 75. Europe Peripheral Drug-Coated Balloon Sales Forecast by Country (2021-2026) & (K Units)
Table 76. Europe Peripheral Drug-Coated Balloon Revenue Forecast by Country (2021-2026) & ($ millions)
Table 77. Middle East & Africa Peripheral Drug-Coated Balloon Sales Forecast by Country (2021-2026) & (K Units)
Table 78. Middle East & Africa Peripheral Drug-Coated Balloon Revenue Forecast by Country (2021-2026) & ($ millions)
Table 79. Global Peripheral Drug-Coated Balloon Sales Forecast by Type (2021-2026) & (K Units)
Table 80. Global Peripheral Drug-Coated Balloon Sales Market Share Forecast by Type (2021-2026)
Table 81. Global Peripheral Drug-Coated Balloon Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 82. Global Peripheral Drug-Coated Balloon Revenue Market Share Forecast by Type (2021-2026)
Table 83. Global Peripheral Drug-Coated Balloon Sales Forecast by Application (2021-2026) & (K Units)
Table 84. Global Peripheral Drug-Coated Balloon Sales Market Share Forecast by Application (2021-2026)
Table 85. Global Peripheral Drug-Coated Balloon Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 86. Global Peripheral Drug-Coated Balloon Revenue Market Share Forecast by Application (2021-2026)
Table 87. Cordis Basic Information, Peripheral Drug-Coated Balloon Manufacturing Base, Sales Area and Its Competitors
Table 88. Cordis Peripheral Drug-Coated Balloon Product Offered
Table 89. Cordis Peripheral Drug-Coated Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 90. Cordis Main Business
Table 91. Cordis Latest Developments
Table 92. Defibtech Basic Information, Peripheral Drug-Coated Balloon Manufacturing Base, Sales Area and Its Competitors
Table 93. Defibtech Peripheral Drug-Coated Balloon Product Offered
Table 94. Defibtech Peripheral Drug-Coated Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 95. Defibtech Main Business
Table 96. Defibtech Latest Developments
Table 97. Abbott Laboratories Basic Information, Peripheral Drug-Coated Balloon Manufacturing Base, Sales Area and Its Competitors
Table 98. Abbott Laboratories Peripheral Drug-Coated Balloon Product Offered
Table 99. Abbott Laboratories Peripheral Drug-Coated Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 100. Abbott Laboratories Main Business
Table 101. Abbott Laboratories Latest Developments
Table 102. REVA Medical Basic Information, Peripheral Drug-Coated Balloon Manufacturing Base, Sales Area and Its Competitors
Table 103. REVA Medical Peripheral Drug-Coated Balloon Product Offered
Table 104. REVA Medical Peripheral Drug-Coated Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 105. REVA Medical Main Business
Table 106. REVA Medical Latest Developments
Table 107. Shimadzu Basic Information, Peripheral Drug-Coated Balloon Manufacturing Base, Sales Area and Its Competitors
Table 108. Shimadzu Peripheral Drug-Coated Balloon Product Offered
Table 109. Shimadzu Peripheral Drug-Coated Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 110. Shimadzu Main Business
Table 111. Shimadzu Latest Developments
Table 112. Opto Circuits Basic Information, Peripheral Drug-Coated Balloon Manufacturing Base, Sales Area and Its Competitors
Table 113. Opto Circuits Peripheral Drug-Coated Balloon Product Offered
Table 114. Opto Circuits Peripheral Drug-Coated Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 115. Opto Circuits Main Business
Table 116. Opto Circuits Latest Developments
Table 117. Biotronik Basic Information, Peripheral Drug-Coated Balloon Manufacturing Base, Sales Area and Its Competitors
Table 118. Biotronik Peripheral Drug-Coated Balloon Product Offered
Table 119. Biotronik Peripheral Drug-Coated Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 120. Biotronik Main Business
Table 121. Biotronik Latest Developments
Table 122. Endologix Basic Information, Peripheral Drug-Coated Balloon Manufacturing Base, Sales Area and Its Competitors
Table 123. Endologix Peripheral Drug-Coated Balloon Product Offered
Table 124. Endologix Peripheral Drug-Coated Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 125. Endologix Main Business
Table 126. Endologix Latest Developments
Table 127. SMT Basic Information, Peripheral Drug-Coated Balloon Manufacturing Base, Sales Area and Its Competitors
Table 128. SMT Peripheral Drug-Coated Balloon Product Offered
Table 129. SMT Peripheral Drug-Coated Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 130. SMT Main Business
Table 131. SMT Latest Developments
Table 132. Philips Healthcare Basic Information, Peripheral Drug-Coated Balloon Manufacturing Base, Sales Area and Its Competitors
Table 133. Philips Healthcare Peripheral Drug-Coated Balloon Product Offered
Table 134. Philips Healthcare Peripheral Drug-Coated Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 135. Philips Healthcare Main Business
Table 136. Philips Healthcare Latest Developments
Table 137. Elixir Medical Basic Information, Peripheral Drug-Coated Balloon Manufacturing Base, Sales Area and Its Competitors
Table 138. Elixir Medical Peripheral Drug-Coated Balloon Product Offered
Table 139. Elixir Medical Peripheral Drug-Coated Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 140. Elixir Medical Main Business
Table 141. Elixir Medical Latest Developments
Table 142. CorMatrix Cardiovascular Basic Information, Peripheral Drug-Coated Balloon Manufacturing Base, Sales Area and Its Competitors
Table 143. CorMatrix Cardiovascular Peripheral Drug-Coated Balloon Product Offered
Table 144. CorMatrix Cardiovascular Peripheral Drug-Coated Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 145. CorMatrix Cardiovascular Main Business
Table 146. CorMatrix Cardiovascular Latest Developments
Table 147. Advanced Cardiac Therapeutics Basic Information, Peripheral Drug-Coated Balloon Manufacturing Base, Sales Area and Its Competitors
Table 148. Advanced Cardiac Therapeutics Peripheral Drug-Coated Balloon Product Offered
Table 149. Advanced Cardiac Therapeutics Peripheral Drug-Coated Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 150. Advanced Cardiac Therapeutics Main Business
Table 151. Advanced Cardiac Therapeutics Latest Developments
Table 152. Edwards Lifesciences Basic Information, Peripheral Drug-Coated Balloon Manufacturing Base, Sales Area and Its Competitors
Table 153. Edwards Lifesciences Peripheral Drug-Coated Balloon Product Offered
Table 154. Edwards Lifesciences Peripheral Drug-Coated Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 155. Edwards Lifesciences Main Business
Table 156. Edwards Lifesciences Latest Developments
Table 157. Impulse Dynamics Basic Information, Peripheral Drug-Coated Balloon Manufacturing Base, Sales Area and Its Competitors
Table 158. Impulse Dynamics Peripheral Drug-Coated Balloon Product Offered
Table 159. Impulse Dynamics Peripheral Drug-Coated Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 160. Impulse Dynamics Main Business
Table 161. Impulse Dynamics Latest Developments
Table 162. Stereotaxis Basic Information, Peripheral Drug-Coated Balloon Manufacturing Base, Sales Area and Its Competitors
Table 163. Stereotaxis Peripheral Drug-Coated Balloon Product Offered
Table 164. Stereotaxis Peripheral Drug-Coated Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 165. Stereotaxis Main Business
Table 166. Stereotaxis Latest Developments
List of Figures
Figure 1. Picture of Peripheral Drug-Coated Balloon
Figure 2. Peripheral Drug-Coated Balloon Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Peripheral Drug-Coated Balloon Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Peripheral Drug-Coated Balloon Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Peripheral Drug-Coated Balloon Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Paclitaxel
Figure 10. Product Picture of Sirolimus
Figure 11. Product Picture of Others
Figure 12. Global Peripheral Drug-Coated Balloon Sales Market Share by Type in 2020
Figure 13. Global Peripheral Drug-Coated Balloon Revenue Market Share by Type (2016-2021)
Figure 14. Peripheral Drug-Coated Balloon Consumed in Hospital
Figure 15. Global Peripheral Drug-Coated Balloon Market: Hospital (2016-2021) & (K Units)
Figure 16. Peripheral Drug-Coated Balloon Consumed in Clinic
Figure 17. Global Peripheral Drug-Coated Balloon Market: Clinic (2016-2021) & (K Units)
Figure 18. Peripheral Drug-Coated Balloon Consumed in Others
Figure 19. Global Peripheral Drug-Coated Balloon Market: Others (2016-2021) & (K Units)
Figure 20. Global Peripheral Drug-Coated Balloon Sales Market Share by Application (2016-2021)
Figure 21. Global Peripheral Drug-Coated Balloon Revenue Market Share by Application in 2020
Figure 22. Peripheral Drug-Coated Balloon Revenue Market by Company in 2020 ($ Million)
Figure 23. Global Peripheral Drug-Coated Balloon Revenue Market Share by Company in 2020
Figure 24. Global Peripheral Drug-Coated Balloon Sales Market Share by Regions (2016-2021)
Figure 25. Global Peripheral Drug-Coated Balloon Revenue Market Share by Region in 2020
Figure 26. Americas Peripheral Drug-Coated Balloon Sales 2016-2021 (K Units)
Figure 27. Americas Peripheral Drug-Coated Balloon Revenue 2016-2021 ($ Millions)
Figure 28. APAC Peripheral Drug-Coated Balloon Sales 2016-2021 (K Units)
Figure 29. APAC Peripheral Drug-Coated Balloon Revenue 2016-2021 ($ Millions)
Figure 30. Europe Peripheral Drug-Coated Balloon Sales 2016-2021 (K Units)
Figure 31. Europe Peripheral Drug-Coated Balloon Revenue 2016-2021 ($ Millions)
Figure 32. Middle East & Africa Peripheral Drug-Coated Balloon Sales 2016-2021 (K Units)
Figure 33. Middle East & Africa Peripheral Drug-Coated Balloon Revenue 2016-2021 ($ Millions)
Figure 34. Americas Peripheral Drug-Coated Balloon Sales Market Share by Country in 2020
Figure 35. Americas Peripheral Drug-Coated Balloon Revenue Market Share by Country in 2020
Figure 36. Americas Peripheral Drug-Coated Balloon Sales Market Share by Type in 2020
Figure 37. Americas Peripheral Drug-Coated Balloon Sales Market Share by Application in 2020
Figure 38. United States Peripheral Drug-Coated Balloon Revenue Growth 2016-2021 ($ Millions)
Figure 39. Canada Peripheral Drug-Coated Balloon Revenue Growth 2016-2021 ($ Millions)
Figure 40. Mexico Peripheral Drug-Coated Balloon Revenue Growth 2016-2021 ($ Millions)
Figure 41. Brazil Peripheral Drug-Coated Balloon Revenue Growth 2016-2021 ($ Millions)
Figure 42. APAC Peripheral Drug-Coated Balloon Sales Market Share by Region in 2020
Figure 43. APAC Peripheral Drug-Coated Balloon Revenue Market Share by Regions in 2020
Figure 44. APAC Peripheral Drug-Coated Balloon Sales Market Share by Type in 2020
Figure 45. APAC Peripheral Drug-Coated Balloon Sales Market Share by Application in 2020
Figure 46. China Peripheral Drug-Coated Balloon Revenue Growth 2016-2021 ($ Millions)
Figure 47. Japan Peripheral Drug-Coated Balloon Revenue Growth 2016-2021 ($ Millions)
Figure 48. Korea Peripheral Drug-Coated Balloon Revenue Growth 2016-2021 ($ Millions)
Figure 49. Southeast Asia Peripheral Drug-Coated Balloon Revenue Growth 2016-2021 ($ Millions)
Figure 50. India Peripheral Drug-Coated Balloon Revenue Growth 2016-2021 ($ Millions)
Figure 51. Australia Peripheral Drug-Coated Balloon Revenue Growth 2016-2021 ($ Millions)
Figure 52. Europe Peripheral Drug-Coated Balloon Sales Market Share by Country in 2020
Figure 53. Europe Peripheral Drug-Coated Balloon Revenue Market Share by Country in 2020
Figure 54. Europe Peripheral Drug-Coated Balloon Sales Market Share by Type in 2020
Figure 55. Europe Peripheral Drug-Coated Balloon Sales Market Share by Application in 2020
Figure 56. Germany Peripheral Drug-Coated Balloon Revenue Growth 2016-2021 ($ Millions)
Figure 57. France Peripheral Drug-Coated Balloon Revenue Growth 2016-2021 ($ Millions)
Figure 58. UK Peripheral Drug-Coated Balloon Revenue Growth 2016-2021 ($ Millions)
Figure 59. Italy Peripheral Drug-Coated Balloon Revenue Growth 2016-2021 ($ Millions)
Figure 60. Russia Peripheral Drug-Coated Balloon Revenue Growth 2016-2021 ($ Millions)
Figure 61. Middle East & Africa Peripheral Drug-Coated Balloon Sales Market Share by Country in 2020
Figure 62. Middle East & Africa Peripheral Drug-Coated Balloon Revenue Market Share by Country in 2020
Figure 63. Middle East & Africa Peripheral Drug-Coated Balloon Sales Market Share by Type in 2020
Figure 64. Middle East & Africa Peripheral Drug-Coated Balloon Sales Market Share by Application in 2020
Figure 65. Egypt Peripheral Drug-Coated Balloon Revenue Growth 2016-2021 ($ Millions)
Figure 66. South Africa Peripheral Drug-Coated Balloon Revenue Growth 2016-2021 ($ Millions)
Figure 67. Israel Peripheral Drug-Coated Balloon Revenue Growth 2016-2021 ($ Millions)
Figure 68. Turkey Peripheral Drug-Coated Balloon Revenue Growth 2016-2021 ($ Millions)
Figure 69. GCC Country Peripheral Drug-Coated Balloon Revenue Growth 2016-2021 ($ Millions)
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles